Introduction
Heat shock proteins (HSPs) with a molecular weight around 70 kDa are a family of highly conserved proteins in various cell types, which predominantly reside in intracellular compartments. As a molecular chaperone, Hsp70 plays an important role in a protein's intracellular life cycle, such as during folding, trafficking and degradation, and this chaperone has recently been considered a pharmacological target (Patury et al., 2009) . Hsp70 (HSPA1A, HUGO GeneID 3303), the major stress inducible member of this family, is also translocated to the plasma membrane of tumour cells, where it provides immunostimulatory signals to the innate immune system (Multhoff et al., 1997; Krause et al., 2004) .
Contrasting with normal tissues, Hsp70 can be detected on the cell surface for more than 50% of human tumours such as gastric, colon, breast and lung carcinomas and, hence, represents a specific marker for diagnosis and therapeutic intervention in cancer therapy (Multhoff et al., 1995) . Notably, metastases show elevated levels of detectable Hsp70 and the amount of membrane-associated Hsp70 is often increased after therapeutic treatment such as chemotherapy or radiation.
It was shown that both intact Hsp70 as well as peptides derived from it can stimulate the lytic activity of natural killer (NK) cells towards Hsp70-positive tumours in vitro and in tumour mouse models. Feasibility, safety and tolerability have been proven for ex vivo Hsp70-peptide stimulated NK cells in a phase I clinical study (Multhoff et al., 2001; Krause et al., 2004; Stangl et al., 2006) . The mechanism of NK-mediated tumour cell lysis was found to be granzyme B-mediated apoptosis independent of perforin (Gross et al., 2003; Krause et al., 2004) .
Regardless of the UICC tumour grade, the survival of patients with non-small cell lung cancer and lower rectal cancer was observed to correlate with the expression of Hsp70 on the tumour cell membranes. Moreover, it was shown that Hsp70 membrane-positive tumours are more resistant to radio-and chemotherapy in vitro, which might result in a shorter life expectancy for patients. These findings indicate that membrane-associated Hsp70 could serve as a negative prognostic marker in cancer therapy.
The mouse monoclonal antibody cmHsp70.1 (Multhoff, 2007) was raised against a peptide immunogen (TKDNNLLG RFELSG) comprising residues 450-463 within the C-terminal substrate binding domain of human Hsp70 (SWISS-PROT entry no. P08107). This antibody was shown to be effective for the sensitive detection of membrane-bound Hsp70 both on human and murine cancer cell lines using biochemical methods, flow cytometry and in vivo imaging (Stangl et al., 2006) , thus providing a promising reagent for tumour diagnosis and, possibly, also radio-immuno therapy.
Compared with full-size antibodies, recombinant Fab fragments offer several advantages such as better tissue penetration and distribution in conjunction with faster clearance from circulation (Holliger and Hudson, 2005) . Furthermore, they often allow efficient bacterial production (Skerra, 1993) , with currently three biopharmaceuticals on the market (Nelson and Reichert, 2009 ). Finally, they lack crossreactivity with Fc receptors, which contributes to signal specificity during in vivo imaging, and they have lower immunogenicity or may be humanized without much effort.
Therefore, with the aim to develop a reagent for the detection of tumours and metastases in cancer therapy, we have cloned the variable gene segments from the cmHsp70.1 hybridoma cell line (Multhoff, 2007) and, after optimization, we have produced several human-murine chimeric versions of the corresponding Fab fragment in Escherichia coli, demonstrating high antigen binding activity in various assays.
Material and methods

Hybridoma cell culture and preparation of the monoclonal antibody
The hybridoma cell line producing the cmHsp70.1 mAb was cultured under exponential growth conditions (until 75% confluency) in RPMI1640 medium (Sigma-Aldrich, Munich, Germany) supplemented with 10% (v/v) heat-inactivated foetal calf serum (FCS), 5.000 U penicillin, 5 mg/ml streptomycin, 100 mM sodium pyruvate and 200 mM L-glutamine. The cells were passaged every 3 days and seeded at a density of 0.5 Â 10 6 per ml. The secreted antibody was isolated from the medium by applying a three-step purification comprising ion exchange chromatography, thiophilic adsorption chromatography and gel filtration.
Edman sequencing
Heavy and light chains of the purified cmHsp70.1 mAb were separated by applying 10 mg to SDS -PAGE using a discontinuous buffer system (Fling and Gregerson, 1986 ) with a glycine-free running buffer (100 mM boric acid, 100 mM Tris base, 0.1% (w/v) SDS) (Zander et al., 2007) . After electroblotting the separated antibody chains onto a PVDF membrane (Millipore, Schwalbach, Germany), the bands were stained with Coomassie Brilliant Blue R-250 and excised. For N-terminal deblocking of both heavy and light chains, Pfu pyroglutamate aminopeptidase (Takara, Otsu, Japan) was used according to a published protocol (Werner et al., 2005) . The excised PVDF strips containing 10-50 pmol of protein were applied to automated N-terminal sequence analysis using a Procise 492 protein sequencer (Applied Biosystems, Weiterstadt, Germany) running in the PVDF pulsed-liquid mode.
Mass-spectrometric sequencing
Antibody samples were reduced with 10 mM dithiothreitol and alkylated using 55 mM iodoacetamide. Heavy and light chains were then either separated via reducing SDS-PAGE followed by tryptic in-gel digestion as described (Shevchenko et al., 1996) or subjected to in-solution digestion with trypsin in 25 mM triethylammonium bicarbonate containing 0.01% (w/v) SDS and 5% (v/v) acetonitrile using a protein:enzyme ratio of 1:20 at 378C over night. The in-solution digest samples were desalted using m-C18 ZipTips (Millipore, Schwalbach, Germany) following the manufacturer's protocol. One pmol of protein digest was used for LC-MS/MS analysis on an LTQ Orbitrap (Thermo Fisher Scientific, Bremen, Germany) coupled to a nano-HPLC (nanoLC Ultra, Eksigent Technologies, CA, USA). Peptides were separated on a self-packed 0.075 Â 15 cm reversed-phase column (Reprosil, Dr Maisch, Ammerbuch, Germany) using a 25 min linear gradient of 0 -35% (v/v) acetonitrile in 0.1% (v/v) formic acid at a flow rate of 300 nl/min. Eluting peptides were measured at a mass resolution of 60 000 and fragmented by collision-induced dissociation (CID). Peptide fragment spectra were collected at both high (30 000) and low (1 000) resolution. Peak list files were generated using Mascot Distiller version 2.2.1.0 (Matrix Science, London, UK) and database searches were performed using the Mascot search engine version 2.2.04 (Matrix Science, London, UK) against the NCBInr database supplemented with the Ig sequences generated in this project. Automatic de novo interpretation of high resolution CID spectra was performed using PEAKS online 2.0 (Bioinformatics Solutions, Waterloo, ON, Canada) and resulting sequences were validated by manual inspection of mass spectra.
Cloning of variable Ig genes from the hybridoma cells
Total RNA was extracted from $10 7 cmHsp70.1 hybridoma cells using the RNeasy Mini Kit (Qiagen, Hilden, Germany) and cDNA was synthesized using the First Strand cDNA Synthesis Kit (Fermentas, St. Leon-Rot, Germany) with an oligo(dT) 18 primer. For subsequent amplification of the V H -C H 1 and V L -C L coding sequences via PCR, oligodeoxynucleotides hybridizing to the 5 0 -regions of the gene subgroups IGHV2 and IGLV1, respectively, were used as forward primers: 5 0 -CAGGTGCAGCTGAAGGAGTCAGG ACC-3 0 and 5 0 -CAGGCTGTTGTGACTCAGGAATCTGC-3 0 . Oligodeoxynucleotides complementary to sites within the mouse C H 1 g1 and C l genes were used as reverse primers: 5 0 -GGTGTGCACACCGCTGGA-3 0 and 5 0 -GACCTAGGAAC AGTCAGC-3 0 . The PCR products obtained for heavy and light chains with Herculase II Fusion DNA polymerase (Stratagene, Heidelberg, Germany) were individually blunt end ligated with the SmaI digested vector pGEM-3z(fþ ) (Promega, Mannheim, Germany), yielding the plasmids pGEM-3z-aHsp70H and pGEM-3z-aHsp70L, respectively. Both DNA strands of the inserts were sequenced with the ABI-Prism 310 Genetic Analyser (Perkin-Elmer Applied Biosystems, Weiterstadt, Germany) using the BigDye terminator kit.
Construction of expression plasmids for the Fab fragment in different versions
For the production of chimeric Fab fragments with human C H 1 g1 and C k constant domains, the aHsp70 V-gene sequences were subcloned-if necessary by using appropriate PCR primers-on the expression vector pASK88 (Schiweck and Skerra, 1995) , using the standardized PstI, BstEII, SacI and XhoI restriction sites (Skerra, 1994a) and resulting in the vector pASK88-Hsp70o. To eliminate the amino acid substitutions in the N-and C-termini of the V H domain caused by this cloning strategy, a double Kunkel mutagenesis (Geisselsoder et al., 1987) with the primers 5 0 -GTCCTGACTCCTTCAGTTGAACTTGGGCCTGCGCTA CG-3 0 (base mismatches underlined) and 5 0 -GGAGACGGT GACCAAGGGTCCCTTGGCCC-3 0 was performed. In a second mutagenesis, the primers 5 0 -GTGCAGATTCCTG AGTGACCACGGCCTGGGCTTTTGTCACAGGGG-3 0 and 5 0 -CGGTTGTTGGTACCACCAATCAGACCAGTGAATAAA TG-3 0 were employed to correct the N-terminus of the light chain and to replace a pair of rare codons at the positions L L47 and I L48 (CTA and ATA) by codons frequently used in E.coli (CTG and ATT). The resulting plasmid was named pASK88-Hsp70ch. For expression of a variant Fab fragment carrying the chimeric heavy chain and a reconstituted original murine l light chain, the plasmid pASK88-Hsp70ch/m was constructed. A PCR with the primers 5 0 -CAGGCTGT TGTGACTCAGGAATCTGC-3 0 and 5 0 -CTCGGTAAGCTTA TTAGGAACAGTCAGCACGG-3 0 was performed using pGEM-3z-aHSP70L as template to yield the light chain coding sequence with a HindIII restriction site (underlined) at the 3 0 -end. After partial digestion with HindIII and SacI, the product was ligated with the correspondingly cut vector pASK88-Hsp70ch. Finally, the plasmid pASK88-Hsp70cm was constructed to produce a fully murine version of the aHsp70 Fab fragment by subcloning the murine C H 1 g1 domain from the plasmid pASK85 (Skerra, 1994b) onto the pASK88-Hsp70ch/m vector via the BstEII and NcoI restriction sites.
Escherichia coli fermentation, recombinant protein production and purification
For the production of the aHsp70 Fab fragments, E.coli JM83 (Yanisch-Perron et al., 1985) cells were transformed with the corresponding pASK88 derivatives. Cultures were grown in 2 l shaker flasks with LB medium supplemented with 100 mg/l ampicillin. Three hours after inducing gene expression at OD 550 ¼ 0.5 with 200 mg/l anhydrotetracycline (aTc; Acros Organics, Geel, Belgium), the periplasmic cell fraction containing the recombinant proteins was extracted as described (Fiedler and Skerra, 1999) by applying mild osmotic shock and EDTA treatment. Recombinant protein purification was carried out via IMAC on Zn(II)-charged IDA-Sepharose (Skerra, 1994a) . The previously described anti-lysozyme Fab D1.3 (Skerra, 1994a) , which served as negative control in the binding assays, was prepared in the same way. Fermenter scale production of Fab fragments was carried out in an 8 l vessel (Schütt Labortechnik, Göttingen, Germany) with E.coli MC4100 cells (Oliver and Beckwith, 1982) , harbouring either the Fab expression plasmid alone or in the presence of the helper plasmid pTUM4 (Schlapschy et al., 2006) , according to a published protocol (Schiweck and Skerra, 1995) . Temperature, pH value and dissolved oxygen concentration were monitored and automatically kept constant during the fermentation runs. Cells were grown at 258C and recombinant protein expression was induced at OD 550 ¼ 20 with 500 mg/l aTc and harvested 2 h after induction. The recombinant Fab protein was purified by IMAC as above, followed by gel filtration on a Superdex 75 HiLoad 16/60 prep grade column (Amersham Pharmacia Biotech, Uppsala, Sweden) with PBS (4 mM KH 2 PO 4 , 16 mM Na 2 HPO 4 , 115 mM NaCl) as running buffer. The purified proteins were analysed by SDS-PAGE and subsequent staining with Coomassie Brilliant Blue R-250 or by analytical gel filtration on a Superdex 75-HR10/30 column (Amersham). Protein concentrations were measured by means of the absorption at 280 nm using calculated extinction coefficients (Gill and von Hippel, 1989) 
Enzyme-linked immunosorbent assay (ELISA)
ELISA experiments were performed according to published procedures (Schlapschy et al., 2004) . Briefly, a 96-well microtiter plate (12 Â 8 well ELISA strips with high binding capacity; Greiner Bio-One, Solingen, Germany) was coated with 50 ml/ well of recombinant human Hsp70 (hHsp70, produced in Sf9 insect cells transfected with a Baculovirus containing the cDNA, purified via the His 6 -tag), recombinant murine immunoglobulin heavy chain-binding protein (BiP, residues 27-577; produced in E.coli and purified via the Strep-tag II (Schmidt and Skerra, 2007) ) or ovalbumin (Sigma-Aldrich), all at a concentration of 20 mg/ml in 5% (w/v) NaHCO 3 . After blocking the wells with 3% (w/v) BSA, the aHsp70 Fab fragment was applied in a dilution series using PBS containing 0.1% (v/v) Tween-20. The bound Fab fragment was detected by applying a rabbit anti-mouse Cl-light chain antibody (Advanced Chemtech, Louisville, KY, USA) in a primary incubation step and a swine anti-rabbit IgG/AP conjugate (Dako, Glostrup, Denmark) in a secondary step, followed by a chromogenic reaction with p-nitrophenyl phosphate (0.5 mg/ml; Applichem, Darmstadt, Germany). Data were fitted by non-linear least squares regression according to the Law of Mass Action using KaleidaGraph software (Voss and Skerra, 1997) .
Real-time biomolecular interaction analysis
Surface plasmon resonance spectroscopy was performed on a BIAcore X Instrument (BIAcore, Uppsala, Sweden). The target hHsp70 (5 mg/ml in 10 mM Na-acetate pH 4.5) was immobilized on a CMD 200I chip (XanTec bioanalytics, Münster, Germany) using an amine coupling kit (GE Healthcare, Freiburg, Germany), resulting in a surface density of ca. 2100 response units (RU). The Fab fragment was injected at a series of appropriate concentrations whereby PBS/T (PBS containing 0.005% (v/v) Tween 20) was used as running buffer. Complex formation was observed at a continuous flow rate of 40 ml/min and the kinetic parameters were determined by fitting the data to a 1:1 Langmuir binding model with the BIAevaluation software version 4.1 (BIAcore). The sensorgrams were corrected by double subtraction of the corresponding signals measured for the in-line control blank channel and an averaged baseline determined from several buffer blank injections (Myszka, 1999) .
Labelling of recombinant proteins
The purified Fab fragments were adjusted to concentrations of 1-4 mg/ml in PBS and mixed with a 4-fold molar amount of 6-[fluorescein-5(6)-carboxamido]hexanoic acid NHS ester (Sigma-Aldrich) dissolved in dry dimethyl formamide (DMF). After 1 h incubation at room temperature, the labelled protein was separated from residual reagent using PD-10 desalting columns (GE Healthcare). The fluorophore/ protein molar ratio was determined by UV/VIS spectrometry using the extinction coefficients of the Fab fragments at 280 nm listed above and of 68 000 M 21 cm 21 for the fluorescein group at 495 nm. On average, the Fab fragments were coupled with two fluorescein molecules. The aHsp70 antibody cmHsp70.1 was dissolved in 100 mM NaHCO 3 (pH 8.5) and reacted with a 10-fold molar amount of 5(6)-carboxyfluorescein NHS ester (Sigma-Aldrich) for 2 h at room temperature. A PD-10 desalting column was used to remove residual reagent and for buffer change to PBS.
Flow cytofluorimetry
Human epithelial colorectal adenocarcinoma cells of the Caco-2 cell line (Fogh et al., 1977) were cultivated in high glucose DMEM medium substituted with 10% (v/v) FCS (PAA Laboratories, Pasching, Austria) and detached from the culture vessels with Accutase (Sigma-Aldrich). The cells were washed in PBS/FCS (PBS containing 10% (v/v) FCS), and $1 Â 10 5 cells were incubated in a total volume of 500 ml of the fluorescein-conjugated Fab fragment, dissolved in PBS/FCS at a concentration of 0.2 mM. After 30 min incubation at 48C, the cells were pelleted and resuspended in 500 ml PBS/FCS. Just prior to the analysis, 10 ml of a 100 mg/ml solution of propidium iodide (PI; Sigma-Aldrich) in PBS was added to the sample. Cells were analysed using a FACSAria Cell-Sorting system (BD Biosciences, Heidelberg, Germany) by exciting the fluorescent dyes at 488 nm. The emitted light of fluorescein and PI, respectively, was detected using 530/30 nm and 695/40 nm band pass filters. Human myelogenous leukaemic cells of the K562 cell line (Lozzio and Lozzio, 1975) were cultivated in RPMI1640 medium substituted with 10% (v/v) FCS. The cells were washed in PBS/FCS and 1 -2 Â 10 5 cells were incubated in a total volume of 10 ml of the fluorescein-conjugated Fab fragment (3.5 mM in PBS) or mAb (1.7 mM in PBS with 0.1% (w/v) sodium azide). Fluorescein-labelled D1.3 Fab or mouse g 1 isotype antibody (BD Biosciences) was used as negative controls. After 30 min incubation in darkness on ice, the cells were washed in 1 ml PBS/FCS and finally resuspended in 500 ml PBS/FCS. Just prior to the analysis, 5 ml of a 100 mg/ ml PI solution in PBS was added, followed by analysis with a FACSCalibur Cell-Sorting system (BD Biosciences) using an excitation wavelength of 488 nm. Data were analysed using the FlowJo software (Tree Star, Ashland, OR, USA). Only viable cells, i.e. negative for PI-staining, were gated for counting.
Immunofluorescence microscopy
Caco-2 cells were grown on microscope slides with media chambers (Nalge Nunc, Naperville, IL, USA) in MEM medium (PAA Laboratories) supplemented with 10% (v/v) FCS and non-essential amino acids. At a confluence of 80-90%, cells were washed twice with PBS/FCS. Then, cells grown on the same slide, but in different chambers, were incubated with the fluorescein-labelled aHsp70 Fab or the D1.3 Fab fragment at concentrations of 1 mM in PBS/FCS for 1 h on ice, followed by a wash step with PBS/FCS and two wash steps with PBS. Cells were fixed by incubation with 3% (w/v) paraformaldehyde in PBS. The reaction was stopped by washing the cells with 100 mM glycine/NaOH pH 7.4 in PBS. After washing again with PBS, cells were counterstained with DAPI (4 0 ,6-diamidino-2-phenylindole, 1 mg/ml in PBS) (Otto, 1990) . Microscopy was carried out using an Axiovert 40 inverse microscope (Carl Zeiss MicroImaging, Göttingen, Germany) with 365/12 nm and 470/70 nm band pass filters for excitation of DAPI and fluorescein, respectively. Digital images were taken with a PowerShot A640 camera (Canon, Krefeld, Germany) using identical exposure and aperture values for the tested Fab fragments. Images taken with UV and blue fluorescence excitation were subsequently superimposed using GIMP software version 2.6 in the layer addition mode.
Results and discussion
Cloning of the Fab fragment of cmHsp70.1 using different expression constructs
The variable genes from the hybridoma cell line cmHsp70.1 were cloned on a well-established expression vector for Fab fragments, pASK88 (Skerra, 1994a; Schiweck and Skerra, 1995) . This vector effects periplasmic secretion in E.coli by means of bacterial signal peptides fused to the mature part of both Ig chains. However, initial attempts to recover the recombinant Fab fragment in a soluble state failed. Thus, the question arose whether deleterious sequence changes due to the cloning procedure-in particular at the 5 0 and 3 0 regions of the V-genes around the standardized restriction sites on the expression vector (Skerra, 1994a )-had occurred.
Based on the amino acid sequence information for the heavy and light chains of the native cmHsp70.1 mAb that were obtained by Edman sequencing and mass-spectrometric analysis, together with the sequences of the amplified cDNAs and the knowledge that this monoconal antibody belongs to the IgG1/l subclass, several deviations to the sequence encoded on the inital expression vector pASK88-Hsp70o were identified ( Fig. 1) : (i) within the N-terminal four to five residues of both chains encoded on the expression vector the cloned sequences were determined by the generic PCR primers, including conserved restriction sites that were employed for cloning; (ii) four residues in the region of the conserved restriction site close to the 3 0 -end of the V L domain; (iii) furthermore, two rare E.coli codons at neighbouring positions (L47 and L48) within the V L region were observed. Consequently, the original sequences of both antibody chains were reconstituted via site-directed mutagenesis, resulting in the expression vector pASK88-Hsp70ch (Fig. 1) . Nevertheless, still only minute amounts of soluble Fab fragment could be purified in corresponding expression experiments.
As it is known that the nature of the constant domains can influence the folding efficiency of Fab fragments in the periplasm of E.coli (Skerra and Plückthun, 1991; MacKenzie et al., 1994; Schiweck and Skerra, 1995) , vectors encoding different chimeric versions of the Fab fragment were constructed (Fig. 1B) : further to pASK88-Hsp70ch, which encodes the murine variable Ig domains in the context of the first human IgG1 heavy chain and k light chain constant domains, the expression plasmid pASK88-Hsp70ch/m was constructed, wherein the human C k gene was replaced by the original murine C l gene. Subsequently, in a third construct dubbed pASK88-Hsp70cm, the human constant C H 1 g1 domain was replaced by its murine ortholog.
Bacterial expression of the recombinant Fab fragment and optimization of conditions
In principle, the chosen vector system (Skerra, 1994a; Skerra, 1994b ) permitted isolation of all Fab constructs via immobilized metal affinity chromatography (IMAC) by means of the His 6 tag that was directly attached to the C-terminus of the Fd fragment (V H C H ; Fig. 1B) . However, the yields of purifyable protein were disappointingly low, merely around 12 mg per litre E.coli culture, for all expression constructs tested.
It is known that many recombinant antibody fragments tend to accumulate as insoluble proteins in the bacterial periplasm, most likely due to aggregation of folding intermediates (Skerra and Plückthun, 1991; Whitlow and Filpula, 1991) . Previous studies have shown that switching constant regions can help improve the yield of soluble and functional Fab produced in E.coli (MacKenzie et al., 1994) . Hence, altogether three different versions of the Fab fragment were compared: one version with human C H 1 g1 and C k domains, one with the C k exchanged by the murine C l domain, and one with both of the original murine constant domains. Switching the light chain constant domain from human C k to murine C l moderately increased the yield of purifyable Fab fragment by a factor of around two (to $24 mg/l) while further substitution of the C H 1 domain did not have a significant effect on the yield ($20 mg/l).
Notably, when the E.coli production of the huC H 1 g1 /muC l Fab fragment was attempted in an 8 l laboratory fermenter, strong cell lysis was observed soon after induction of expression, and after IMAC purification merely ca. 125 mg recombinant Fab were obtained per litre culture medium (at a cell density OD 550 ¼ 30).
In a different approach, we sought to boost folding of the recombinant Fab fragment by overexpression of periplasmic chaperones. To this end, the E.coli cells were cotransformed with the previously described helper plasmid pTUM4 (Schlapschy et al., 2006) , which encodes two thiol-disulphide oxidoreductases, DsbA and DsbC, and two peptidyl-prolyl cis/trans-isomerases (PPIases) with chaperone activity, FkpA and SurA. To our surprise, the yield of soluble recombinant Fig. 1 . Variable region sequences and expression constructs for the recombinant Fab fragment of the cmHsp70.1 antibody. (A) Alignment of amino acid sequences derived from the cDNA, the originally constructed expression vector pASK88-Hsp70o and the corrected versions pASK88-Hsp70ch/m, which were used for the successful production of the Fab fragment in E.coli. Sequence stretches determined by Edman degradation of the hybridoma protein are framed and those identified by MS/MS-sequencing are underlined. The part of the cDNA sequence that was determined by the primer used for PCR amplification and cloning is indicated by small letters. Amino acid sequences are numbered according to Kabat et al. (1991) . (B) Schematic diagram of bacterial expression constructs with human constant domains (pASK88-Hsp70ch), with the chimeric version ( pASK88-Hsp70ch/m), and with murine constant domains ( pASK88-Hsp70cm). The bacterial signal peptides (OmpA and PhoA), the His 6 affinity tag as well as important regulatory elements such as the tetA promoter/ operator (tet p/o ), Shine/Dalgarno sequence (SD) and lipoprotein terminator (t lpp ) are labelled.
Fab fragment was dramatically increased to ca. 18 mg per litre culture medium, i.e. by more than a factor 100. Purity and monodispersity of the recombinant aHsp70 Fab fragment was shown by SDS -PAGE and gel filtration (Fig. 2) . Disulphide bond formation and isomerisation as well as cis/ trans-isomerisation of prolyl-iminopeptide bonds are known to be slow processes, each of which may be rate-limiting for heterologous protein folding. Thus, providing additional enzymes in the periplasmic compartment that can catalyse these reactions has obviously led to the remarkable increase in yield. For recombinant Ig fragments, this finding is astonishing as earlier studies have indicated that despite such catalysts may be necessary they do not appear to be the limiting factor for the formation of soluble Fab or scFv fragments (Knappik and Plückthun, 1995) . Although at present we can only speculate which of the four folding catalysts encoded on pTUM4 might be responsible for the strong increase in folding efficiency, it seems likely that the PPIases SurA and FkpA play a role in this case (Horne and Young, 1995; Rouviere and Gross, 1996) because there exist one conserved cis-Pro residue ( position 141) in the constant domain of the light chain and two further cis-residues in the heavy Ig chain ( positions 149 and 151). Both PPIases also seem to act as chaperones with general folding enhancer function (Behrens et al., 2001; Baneyx and Mujacic, 2004) . In particular, FkpA was shown to improve the periplasmic production of soluble antibody fragments independent of cis-Pro residues (Bothmann and Plückthun, 2000) .
Functional characterization of the aHsp70 Fab fragment
The recombinant aHsp70 Fab fragment bound its target Hsp70 selectively and with high affinity. A typical saturation curve was observed in ELISA experiments with the purified Fab fragment when recombinant Hsp70 was immobilized to the microtitre plate. This activity was specific as no binding was detectable with the closely related HSP70 family member BiP (Munro and Pelham, 1986) or with the dummy target (Schlapschy et al., 2006) . (B) Elution profile from analytical gel filtration of the IMAC-purified aHsp70 Fab on a Superdex 75-HR10/30 column in the presence of PBS. The molecular size standards bovine serum albumin (66 kDa), ovalbumin (43 kDa), bovine carbonic anhydrase (29 kDa) and myoglobin (17.6 kDa) eluted at 9.08 ml, 9.73 ml, 11.09 ml and 11.92 ml, respectively (not shown). Using regression analysis, an apparent molecular weight of 35.5 kDa was deduced for the aHsp70 Fab fragment (calculated: 47.2 kDa). ovalbumin (Fig. 3) . The apparent dissociation constant for the interaction with Hsp70 in these experiments was 5.8 + 0.2 nM.
Furthermore, Biacore measurements with covalently immobilized Hsp70 were performed, revealing a K D value of 34.5 + 6 nM for the aHsp70 Fab fragment (Fig. 3B) , respectively. The higher K D value from the Biacore measurements compared with the ELISA may be explained by the different buffer conditions as it is known that Hsp70 can adopt distinct conformations depending on the presence of divalent cations, for example (Wu et al., 2004) .
Finally, we investigated whether the aHsp70 Fab fragment binds its target in the membrane-bound form on human cancer cells. Indeed, adenocarcinoma cells of the human Caco-2 cell line (Fogh et al., 1977) and myelogenous leukaemic cells of the K562 cell line (Lozzio and Lozzio, 1975) gave rise to clearly positive and specific staining in flow cytofluorimetry (Fig. 4) . The Hsp70 membrane expression pattern, as determined with the intact cmHsp70.1 mAb, was identical to that seen for the recombinant Fab fragment. This staining is a unique feature since other available antibodies against Hsp70 recognize this antigen on Western blots and in ELISA but do not cross-react with the membrane-bound form of Hsp70 (Multhoff, 2007) . The specific binding of the aHsp70 Fab fragment to the membrane-located antigen Hsp70 was further confirmed by immunofluorescence microscopy of Caco-2 cells (Fig. 5) .
Conclusions
The cytosolic protein Hsp70 is frequently expressed on the cell surface of human tumours but not on the corresponding normal tissues. Moreover, therapeutic intervention causes an up-regulation of Hsp70 membrane expression selectively on cancer cells. Thus, Hsp70 constitutes a potential target for in vivo imaging. We developed the Hsp70 specific antibody cmHsp70.1 which detects membrane-bound Hsp70 on the cell surface of viable tumour cells.
Here we have determined the V-gene sequences and cloned the cDNA for the variable heavy and light chains from the hybridoma cell line cmHsp70.1. The V-regions were assigned to the murine subgroups IGHV2 and IGLV1, respectively, using the international ImMunoGeneTics information system (Elemento and Lefranc, 2003) .
After proper engineering of the protein and optimization of the expression system, a fully functional recombinant aHsp70 Fab fragment could be produced in reasonable amounts in E.coli. The folding helper plasmid pTUM4, which encodes four E.coli periplasmic disulphide oxidoreductases and PPIases with chaperone activity, played a crucial role in this respect. The poor folding efficiency that was observed here for the recombinant Fab fragment in the bacterial host may be a feature of Ig chains rich in cis-Pro residues.
Potent binding activity of the resulting fluorescein-labelled aHsp70 Fab fragment in flow cytofluorimetry and immunofluorescence microscopy demonstrates its applicability for the specific detection of the medically relevant tumour marker. This should prompt the application of this recombinant antibody fragment for tumour-targeted bio-imaging.
